loader
Please Wait
Applying Filters...

Approved Drug Products containing NCGC00025000-09 listed in the FDA Orange Book. Original Data : FDA Website

Menu
$ API Ref.Price (USD/KG) : 82Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2TARO

02 1STRIDES PHARMA

03 1AAIPHARMA LLC

04 1ALMIRALL

05 1AUROBINDO PHARMA USA

06 1CHARTWELL RX

07 1COSETTE

08 1ENCUBE

09 1FOUGERA PHARMS

10 1HERITAGE PHARMA

11 2JANSSEN PHARMA

12 2JANSSEN PHARMS

13 1KRAMER

14 1MYLAN

15 2PADAGIS ISRAEL

16 1SENORES PHARMS

17 1SUN PHARM INDUSTRIES

18 1TASMAN PHARMA

19 2TEVA

20 1XIROMED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD : No

TE Code : AB

KETOCONAZOLE

Brand Name : KETOCONAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 2018-06-18

Application Number : 210457

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

02

arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : KETOCONAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Approval Date : 1999-06-15

Application Number : 75319

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

03

arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : KETOZOLE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 2%

Approval Date : 2002-12-18

Application Number : 75638

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : XOLEGEL

Dosage Form : GEL;TOPICAL

Dosage Strength : 2%

Approval Date : 2006-07-28

Application Number : 21946

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : NIZORAL

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 18533

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : NIZORAL

Dosage Form : CREAM;TOPICAL

Dosage Strength : 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1985-12-31

Application Number : 19084

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : NIZORAL

Dosage Form : SHAMPOO;TOPICAL

Dosage Strength : 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1990-08-31

Application Number : 19927

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

08

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : NIZORAL

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 100MG/5ML

Approval Date : 1986-11-07

Application Number : 70767

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

09

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : NIZORAL ANTI-DANDRUFF

Dosage Form : SHAMPOO;TOPICAL

Dosage Strength : 1%

Approval Date : 1997-10-10

Application Number : 20310

RX/OTC/DISCN : OTC

RLD : Yes

TE Code :

blank

10

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

KETOCONAZOLE

Brand Name : EXTINA

Dosage Form : AEROSOL, FOAM;TOPICAL

Dosage Strength : 2%

Approval Date : 2007-06-12

Application Number : 21738

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank